These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18700911)

  • 1. Long-term data in the treatment of psoriasis.
    Thaçi D
    Br J Dermatol; 2008 Aug; 159 Suppl 2():18-24. PubMed ID: 18700911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psoriasis in the era of biologics].
    Torres T; Velho GC; Sanches M; Selores M
    Acta Med Port; 2010; 23(3):493-8. PubMed ID: 20654269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developments in systemic immunomodulatory therapy for psoriasis.
    Berger EM; Gottlieb AB
    Curr Opin Pharmacol; 2007 Aug; 7(4):434-44. PubMed ID: 17627886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
    Tzu J; Kerdel F
    Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of moderate to severe plaque psoriasis (part I): clinical update on antitumor necrosis factor agents.
    Sobell JM; Kalb RE; Weinberg JM
    J Drugs Dermatol; 2009 Feb; 8(2):147-54. PubMed ID: 19213230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of moderate-to-severe psoriasis: prescreening and monitoring psoriatic patients on biologics.
    Levine D; Strober BE
    Semin Cutan Med Surg; 2010 Mar; 29(1):28-34. PubMed ID: 20430305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approach to managing patients with nail psoriasis.
    Reich K
    J Eur Acad Dermatol Venereol; 2009 Sep; 23 Suppl 1():15-21. PubMed ID: 19686381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
    Alwawi EA; Krulig E; Gordon KB
    Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of biologicals in psoriasis].
    Friedrich M; Philipp S; Sabat R; Asadullah K; Sterry W
    Z Rheumatol; 2003 Oct; 62(5):439-49. PubMed ID: 14579031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infectious risk].
    Calabuig E; Salavert M
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prognosis in patients with psoriasis.
    Gulliver W
    Br J Dermatol; 2008 Aug; 159 Suppl 2():2-9. PubMed ID: 18700909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric psoriasis: updates in biologic therapies.
    Sukhatme SV; Gottlieb AB
    Dermatol Ther; 2009; 22(1):34-9. PubMed ID: 19222515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of moderate-to-severe plaque psoriasis.
    Salgo R; Thaçi D
    G Ital Dermatol Venereol; 2009 Dec; 144(6):701-11. PubMed ID: 19907408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etanercept provides a more physiological approach in the treatment of psoriasis.
    Altomare G; Ayala F; Berardesca E; Chimenti S; Giannetti A; Girolomoni G; Lotti T; Martini P; Peserico A; Guerra AP; Vena GA
    Dermatol Ther; 2008 Oct; 21 Suppl 2():S1-14. PubMed ID: 18837727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic options in the treatment of psoriasis and atopic dermatitis.
    Gottlieb AB
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S3-16. PubMed ID: 15968262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinician's paradigm in the treatment of psoriasis.
    Lebwohl M
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S59-69. PubMed ID: 15968265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort.
    Ahlehoff O; Skov L; Gislason G; Gniadecki R; Iversen L; Bryld LE; Lasthein S; Lindhardsen J; Kristensen SL; Torp-Pedersen C; Hansen PR
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1128-34. PubMed ID: 25303139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug survival rates for tumour necrosis factor-α antagonists in psoriasis.
    Burden AD
    Br J Dermatol; 2011 May; 164(5):940-1. PubMed ID: 21518327
    [No Abstract]   [Full Text] [Related]  

  • 19. Psoriasis: what is new in nonbiologic systemic therapy in the era of biologics?
    Kanwar AJ; Yadav S; Dogra S
    Indian J Dermatol Venereol Leprol; 2010; 76(6):622-33. PubMed ID: 21079305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unmet treatment need for moderate to severe psoriasis: results of a survey and chart review.
    Christophers E; Griffiths CE; Gaitanis G; van de Kerkhof P
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):921-5. PubMed ID: 16922938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.